New studies raise the possibility that GLP-1 medications beat aspirin in reducing colorectal cancer risk, and may improve ...

Findings from a real-world, head-to-head comparison show greater colorectal cancer risk reduction and safety with the use of ...

ABSTRACT: Objective: This study investigates the effects of tamoxifen, a selective estrogen receptor modulator, and letrozole, an aromatase inhibitor, on the endometrium in a rat model. It further ...

ESTERO, FL / ACCESS Newswire / August 18, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending drug delivery technology, today ...

Faculty of Medicine, Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Shatin. (K.G.T., G.G.W., L.C., R.Z., X.W., L.N.-H., B.W.L., Y.W ...

Aspire intends to request "fast track" approval on FDA application for its high-dose aspirin product HUMACAO, PR AND NEW YORK, NY / ACCESS Newswire / April 9, 2025 / Aspire Biopharma Holdings, Inc.

When you pop a prescription pill into your mouth, you trust it to address the issue it was meant to fix. But what really happens? How is your body processing the drugs and what happens if the dosage ...

The Nature Index 2024 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

If you're over the age of 60, you've likely seen headlines in the last couple of years warning against previous medical advice to take aspirin as a preventative measure against heart attack and stroke ...